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Abstract Regulation of the microtubule cytoskeleton is
of pivotal importance for neuronal development and
function. One such regulatory mechanism centers on
microtubule plus-end tracking proteins (?TIPs): struc-
turally and functionally diverse regulatory factors, which
can form complex macromolecular assemblies at the
growing microtubule plus-ends. ?TIPs modulate important
properties of microtubules including their dynamics and
their ability to control cell polarity, membrane transport
and signaling. Several neurodevelopmental and neurode-
generative diseases are associated with mutations in ?TIPs
or with misregulation of these proteins. In this review, we
focus on the role and regulation of ?TIPs in neuronal
development and associated disorders.
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Introduction
Microtubules (MTs) are one of the major types of filaments
that constitute the eukaryotic cytoskeleton. Over the years,
MTs have emerged as key players in cellular processes
such as vesicle and organelle transport, DNA segregation
during mitosis, cell migration and maintenance of cell
polarity. Neurons are among the most complex and
polarized cells, whose distinct morphology allows them to
establish intercellular connections and propagate chemical
and electrical signals across the nervous system. Mature
neurons typically extend multiple processes, one of which
(the axon) serves as a transmitter whereas others (the
dendrites) act as receivers of input from other neurons.
MTs are important for numerous functions in nerve cells
(reviewed in [1–3]), such as long-range transport of cargo
and neuron-specific processes like growth cone guidance.
Indeed, MTs are indispensable for neurodevelopment, and
many neurological diseases stem from defects in the MT
cytoskeleton or its regulation.
Evidence for the existence of MTs was first obtained
from electron microscopy (EM) data in the 1950s (re-
viewed in [4]). Prior to the development of EM, fibrillar
structures had already been described as part of the mitotic
spindle and cytoplasm. However, interpretative differences
and technical limitations of early microscopy made it
challenging to identify unity among observations [4]. It
therefore was not until 1963 that MTs were acknowledged
as distinct structures and named by Slautterback, Ledbetter
and Porter [5, 6]. Today, we know that MTs are hollow
tubes with a diameter of approximately 25 nm. MTs are
typically assembled from 13 laterally associating protofil-
aments, which in turn consist of a, b-tubulin dimers
aligned in a head-to-tail fashion. As a consequence of
tubulin dimer polarity, MTs possess polarity throughout,
which results in distinct ends of the polymer: the minus-
and the plus-end, exposing a- and b-tubulin, respectively.
MTs alternate between rapid phases of growth and
shrinkage, a behavior termed ‘dynamic instability’ [7]. A
transition from shrinkage to growth is called a rescue,
whereas the opposite transition is referred to as a
catastrophe.
Dynamic instability allows MTs to be swiftly remodeled
in response to environmental cues. The MT cytoskeleton is
suitable for rapidly sensing and responding to changes in
the intracellular environment. To this end, the MT
cytoskeleton acts in concert with a large number of proteins
(MAPs for MT-associated proteins) that either influence
MTs themselves or relay signals from the MT cytoskeleton
to other parts of the cell. MAPs are known to regulate MT
behavior such as stability, assembly, bundling and
targeting by associating with specific parts of the MT lat-
tice or by interacting with the soluble tubulin pool. Well-
characterized neuronal MAPs include MAP2 and tau,
which maintain a polarized, mutually exclusive distribution
and decorate MT bundles in dendrites and axons, respec-
tively. Both proteins stabilize MTs and are able to induce
MT bundling (reviewed in [8]). Abnormal phosphorylation
of tau triggers its dissociation from MTs and causes tau to
aggregate, resulting in the formation of potentially toxic
tau deposits (neurofibrillary tangles) found in the brains of
patients suffering from Alzheimer’s disease (AD) and other
tauopathies. This process is accompanied by degradation of
the axonal MT cytoskeleton, suggesting a model in which
dissociation of tau results in MT instability. It should be
noted, however, that the precise hierarchy of events during
the onset of AD remains unclear. Additional roles for tau
are still emerging and may shed new light on the biology of
tauopathies (reviewed in [9]). Among these is the regula-
tion of the subcellular distribution of MAPs that
specifically bind to the growing MT plus-end [10], the
subclass of MAPs that this review will focus on.
MT dynamics are most pronounced at the plus-end.
Although growth events have been observed at the MT
minus-end [11], in cells minus-ends are often anchored or
stabilized, restricting their dynamic behavior [12]. At the
growing plus-end, freshly polymerized MT stretches
contain GTP-loaded b-tubulin as opposed to the GDP-
bound subunits present in the MT lattice, resulting in a
so-called GTP cap. Moreover, the structures of poly-
merizing and depolymerizing MT plus-ends are different
[13]. The unique chemical environment of the polymer-
izing MT plus-end grants it its own interactome within
the realm of MAPs, consisting of MT plus-end tracking
proteins (?TIPs; reviewed in [14–16]). ?TIPs display a
large structural and functional variation between indi-
vidual proteins. However, a common theme sets them
apart from other MAPs: ?TIPs associate with the poly-
merizing MT plus-end, where they act as powerful
regulators of MT dynamics and MT interactions with
other structures.
In this review, we use the neuronal MT cytoskeleton to
illustrate the role of ?TIPs in the development of one of
the most polarized and complex cell types. Before dis-
cussing plus-end tracking mechanisms and highlighting the
roles and regulation of various ?TIPs in neurons, we touch
upon the function of the MT cytoskeleton in the developing
and mature nervous system. Moreover, we highlight the
role of ?TIPs in neurodegenerative and neurodevelop-
mental diseases. We conclude this review with an outlook
on the future of neuronal ?TIP research and briefly discuss
the drug target potential of these pivotal proteins.
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Microtubules in neurons
Neurons are derived from progenitor cells located in the
ventricular zone deep inside the brain, necessitating young
neurons to migrate large distances into remote regions.
During their journey, neurons undergo dramatic changes in
morphology and establish complex polarity. Even mature
neurons must remain plastic as connections between neu-
rons, synapses, are continuously rewired in response to
stimuli. This intricate development relies heavily on both
the MT and the actin cytoskeleton, on their crosstalk and
on their accessory proteins. For a detailed analysis of the
role of the cytoskeleton and in particular MTs during
neuronal development, we refer the reader to a number of
excellent reviews [1–3, 17]. Here, we briefly highlight
some of the main events involving MTs during the matu-
ration of multipolar neurons. It should be noted that the
development of neurons extending a single process,
unipolar neurons, is considerably different [18].
Microtubules during neurite formation and axon
outgrowth
Neurons start out as spherical, unpolarized cells with a MT
organization similar to that commonly found in mam-
malian cells (Fig. 1a). In young neurons, MTs mainly
nucleate from the centrosome, with MT minus-ends
pointing inward and plus-ends oriented towards the cell
periphery [19]. Upon differentiation, neurons undergo
symmetry breaking. During this event, the neuron extends
multiple processes that start as small buds on the mem-
brane and elongate to form thin protrusions [20]. These
early protrusions, termed neurites, mature into axons and
dendrites when the neuron polarizes. It has been proposed
that neurite formation is powered, at least in part, by MT
sliding. One model suggests that MAP2c (microtubule-as-
sociated protein 2c) induces stable MT bundles, which
translocate to the membrane where they exert a dynein-
dependent force to trigger protrusion formation [21].
Another model proposes that the motor protein kinesin-1
powers the displacement of MTs along other MTs, exerting
a mechanical force on the membrane which results in
neurite extension [22] (Fig. 1b).
Shortly after neurite extension, the axon is formed
(Fig. 1c). This event is preceded by local stabilization of
MTs in the pre-axonal neurite [23]. As the newly formed
axon starts to elongate, it relies on stable MT tracks for the
transport of proteins and organelles necessary for the for-
mation of new axonal segments [24]. The direction of axon
outgrowth is determined by the growth cone, which probes
the extracellular environment to allow non-random estab-
lishment of synaptic connections. Amidst the actin, which
drives invasion of the extracellular matrix (reviewed in
[25]), an array of MTs controls the direction in which the
growth cone advances (Fig. 1d; [26]). The MT array
assumes a looped conformation in pausing growth cones
[27], while active growth cones maintain a dynamic MT
array. These MTs probe the growth cone cortex and
respond to guidance signals by being stabilized or desta-
bilized, prompting the growth cone to turn towards or away
from the guidance cue, respectively [24, 28]. As the axon
matures further, it branches to allow higher interconnec-
tivity. Branch formation is accomplished by splaying of
tau-decorated MT bundles at branching sites. Here,
dynamic MTs invade actin-rich areas close to the mem-
brane to form a collateral branch [29]. Thus, while dynamic
MTs play only a minor role in neurite outgrowth, they are
crucial for axon polarization, pathfinding and branching.
Microtubules during dendrite maturation
Dendritic differentiation occurs later in development
than axogenesis and prompts dramatic changes to the
soon-to-be dendritic MT infrastructure. Prior to dendri-
togenesis, mammalian precursor neurites cycle between
phases of growth and shrinkage and maintain *80 %
plus-end out1 MT directionality [30]. Perhaps the most
striking feature of the dendritic MT cytoskeleton is the
appearance of MTs with their minus-ends oriented
towards the dendritic tips [31, 32] (Fig. 1e). However, it
should be noted that the ratio between minus- and plus-
end out MT orientations changes per neuron type and
even differs between regions of the same dendrite. In
invertebrates, as much as ninety percent of dendritic
MTs are oriented minus-end out [33, 34]. Differences in
MT orientations between axon and dendrites likely
contribute to proper targeting of specific cargo by
enabling transport by specific motor proteins. While
dendrites branch more than axons, the behavior of MTs
during this process has been studied less extensively.
Specialized Golgi compartments called Golgi outposts
were identified as potential sites of MT nucleation in
centrosome-free Drosophila neurons [35], and were
shown to localize to dendritic branch points [36]. Since
axon branching depends on dynamic MTs arising from
splayed bundles, it seems likely that dynamic MTs
nucleated at Golgi outposts fulfill a similar role in
dendritic branching [35].
1 With the terminology ‘plus-end out’, we designate MTs with their
plus-end oriented towards the cell periphery, or towards dendritic or
axonal tips. ‘Minus-end out’ indicates MTs of which the minus-end is
oriented towards the cell periphery or process tips.
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Microtubules and synapses
The formation of synapses, connections between the axon
of one neuron and the dendrite of another, is the final and
ongoing step in neuronal maturation. Excitatory synapses
are formed on dendritic spines, which are actin-rich pro-
trusions on the dendrite that scaffold the post-synaptic
density. The absence of MAP2-positive MTs in dendritic
spines raised the belief that the MT cytoskeleton remained
confined to the dendritic shaft [37]. However, visualization
of the behavior of MTs and MT plus-ends revealed that
dynamic MTs transiently invade dendritic spines by poly-
merizing from proximal sites [38–41]. MT-depolymerizing
drugs such as nocodazole markedly reduce the number of
spines, while the number of dendrites remains unaffected
[38]. Nocodazole also blocks the spine-inducing effect of
the growth factor BDNF (brain-derived neurotrophic fac-
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Fig. 1 Microtubule organization and function during neurodevelop-
ment. Cultured dissociated neurons start out as spherical, unpolarized
cells with MTs oriented with their plus-ends towards the plasma
membrane (a). Upon symmetry breaking, neurite extension is thought
to be facilitated by motor proteins, which were proposed to push MTs
and thus exert a force on the membrane to form protrusions (b).
Young neurons possess multiple neurites and maintain a mainly plus-
end out MT orientation (c). While remaining neurites cycle between
phases of growth and shrinkage, one neurite rapidly extends to form
the axon. In this neurite, MTs become stabilized and MT bundles are
decorated with the axon-specific MAP tau, while MTs remain
oriented plus-end out. The rate of advance and the directionality of
axon outgrowth is controlled by the growth cone, a specialized
structure at the tip of the axon that contains a dynamic array of MTs.
Local stabilization of a MT in one of the filopodia of the growth cone
prompts the growth cone to turn in that direction (d). Later in
development, the remaining neurites differentiate into dendrites.
Dendrites acquire unique antiparallel MT bundles decorated by
MAP2, presumably contributing to selective cargo trafficking (e). The
post-synapse is present at the tips of dendritic spines. Targeting of
dynamic MTs to spines triggers morphological changes and alters
synaptic strength, possibly by allowing the delivery of specific cargo
to the spine or activating signaling processes (f)
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induced spine formation [40]. Finally, depletion of end-
binding protein 3 (EB3), a key scaffolding factor at the MT
plus-end and regulator of MT dynamics discussed below,
reduces the amount of spines [40]. These studies imply
dynamic MTs as modulators of neuronal plasticity. ?TIPs
involved in synaptic remodeling may rely on dynamic MT
plus-ends as a means of reaching spines targeted for
remodeling [38]. Other candidate regulatory mechanisms
involve the facilitation of cargo delivery to the postsynaptic
terminal [1] (Fig. 1f), though it remains to be elucidated
exactly which events are at play.
Microtubule plus-end tracking proteins in neurons
MT behavior during neurodevelopment has been cata-
logued extensively. However, research has only just begun
to uncover which factors control MT dynamics and how
MTs are able to relay intricate signals in neurons. Many of
the cellular processes and the molecular mechanisms that
underlie them remain unknown to date.
Since ?TIPs have emerged as potent MT regulators,
they are excellent candidates to control MTs and relay their
signals during neuronal development and homeostasis.
Indeed, numerous ?TIPs have already been linked to
neurodevelopmental functions (Table 1). New ?TIPs are
still discovered on a regular basis, and it is likely that
additional roles for ?TIPs in neurons will be uncovered in
the future. Current knowledge suggests that, based on their
mode of association with MTs, ?TIPs can be divided into
three categories: end-binding proteins (EBs), EB-depen-
dent ?TIPs and EB-independent ?TIPs. It should be noted
that even in the case of EB-independent ?TIPs, there is
crosstalk between these ?TIPs and EBs albeit indirectly.
Therefore, none of these categories can be regarded as fully
independent.
End-binding proteins
EBs are at the core of the MT plus-end interactome. They
are known to regulate MT behavior both autonomously and
by providing a structural scaffold for other ?TIPs [42–44].
EB plus-end tracking depends on an N-terminal calponin
homology (CH) domain that grants MT affinity [45]. It has
been shown that EB proteins associate with the MT plus-
end by a CH-dependent nucleotide sensing mechanism [46,
47]. MT binding is regulated by a negatively charged
C-terminal domain, which repels the negatively charged
MT lattice and thereby contributes to specificity for the MT
plus-end [48]. In addition, C-terminal coiled-coil and EB-
homology domains mediate homo- and heterodimerization
as well as interaction with other proteins including ?TIPs
[49, 50].
EBs mainly function as scaffolding proteins at the MT
plus-end, where they form a hub for other ?TIPs to asso-
ciate with and thereby regulate local protein composition
and MT dynamics. This is illustrated by the fact that EBs
promote catastrophes when reconstituted with tubulin in
biochemical preparations, while they reduce the number of
catastrophes and promote continuous MT growth in cells.
This suggests that EBs primarily act on other MT regula-
tors in cells rather than autonomously [44]. Plus-end bound
EBs rapidly exchange with the cytosolic pool, providing a
rapidly remodeling platform for protein binding [43, 51].
Quantitative proteomic studies of non-neuronal cell lines
have revealed that EBs are the most abundant plus-end
binding proteins: the EB family outnumbers the second
most abundant ?TIPs by factors of approximately 7–30 in
cultured fibroblasts [52, 53]. While technical limitations
arising from sample heterogeneity have hampered large-
scale quantitative proteomics studies in nerve cells [54], it
is expected that EBs dominate neuronal MT plus-ends in a
similar fashion as in cultured fibroblasts. The relatively
high concentration of EBs compared to other ?TIPs offers
a simple explanation for how EB-decorated plus-ends are
efficiently formed and maintained. Such a hub provides
cells with an extra layer of control to regulate large num-
bers of ?TIPs with minimal changes to the MT
cytoskeleton itself, making it easier to retain MT integrity
and reliant functions alongside.
In mammalian cells, the EB family is represented by
three members (EB1, EB2 and EB3), which all bind to MT
plus-ends but differ in their affinity for MT tips, phos-
phorylation and affinity for binding partners [44, 55–59].
EB1 and EB2 appear to be expressed ubiquitously, while
EB3 is strongly expressed in muscle and brain tissue [60,
61]. During neurodevelopment, EB1 expression decreases
while EB3 expression is upregulated [38]. Axon extension
coincides with EB1 expression in neuroblastoma cells [62].
In Drosophila¸ depletion of EB1 impairs axon outgrowth
and leads to the disorganization, but not loss, of MTs [63].
Other studies also point in the direction of a role for EB1 in
axogenesis [64], and suggest a differential role of EB
proteins in neurite formation. EB1 and EB3 have a positive
role in neurite outgrowth, while EB2 has a negative effect
[65], possibly because EB1 and EB3 have a higher affinity
than EB2 for MT-stabilizing partners [56, 66]. EB3 has
been specifically implicated in neuritogenesis in the con-
text of actin-MT interactions [67], suggesting that the
mechanisms underlying the importance of EBs for con-
trolling neuronal morphogenesis can be quite complex.
Apart from scaffolding other ?TIPs, EBs may also aid
the capture of MT plus-ends for regulatory purposes. For
example, MTs are proposed to rely on EB3 and Drebrin to
enter actin-rich spines. Drebrin interacts with the growing
MT plus-end via an unconventional interaction with EB3
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[67], and is enriched in spines by binding to F-actin [68].
Drebrin localization becomes enhanced in spines upon
NMDA (N-methyl-D-aspartate) receptor activity, where-
upon Drebrin is believed to capture EB-decorated MT plus-
ends near or in the spine neck and thereby guide dynamic
MT entry into spines. Accordingly, Drebrin overexpression
and increased amounts of F-actin upregulate the number of
MT entries into spines [41].
Interestingly, another neuron-specific role for EB1/3
was reported that does not depend on plus-end tracking.
EBs are enriched in the axon initial segment (AIS) of
hippocampal neurons, where they contribute to AIS
integrity and maintenance [69]. This possibly contributes to
enhanced MT stability in the AIS [69], although the precise
mechanism remains unclear.
EB-dependent 1TIPs: CAP-Gly proteins
Most known EB-dependent ?TIPs can be divided in two
categories, depending on their mode of association with EB
proteins. The first category consists of a minority of ?TIPs
that contain an evolutionarily conserved cytoskeletal-as-
sociated protein glycine-rich (CAP-Gly) domain, which
associates with EEY/F motifs in the C-terminus of EB
proteins and tubulin [70–73].
An example of one such CAP-Gly domain-containing
?TIP is p150glued: the largest out of eleven subunits of the
dynactin complex. Dynactin is essential to nearly all
functions of dynein, the most prominent minus-end direc-
ted motor protein [74]. Dynein plays a particularly
important role in axons, wherein transport into the soma
relies on minus-end directed transport due to the uniform
plus-end out orientation of MTs. It is likely that multiple
mechanisms contribute to dynein activation at different
locations along the neuron [74]. At the MT plus-end
specifically, one such model explains how retrograde
transport is initiated when the dynamic MT plus-end loa-
ded with p150glued and other dynein regulators encounters
minus-end directed cargos ([75] and reviewed in [74]).
While the role of dynactin in dynein plus-end targeting
appears to differ between organisms [74], research suggests
that dynactin accumulation at the MT plus-ends in axons of
murine dorsal root ganglia (DRG) neurons contributes to
long-range retrograde transport by recruiting dynein to
vesicles [76]. It has been postulated that this function is
exerted by a neuron-specific p150glued isoform, which
reduces the frequency of catastrophes and thus increases
MT stability [77].
Although p150glued binds to EBs directly, its affinity
for MT plus-ends appears not to be very high. In cells,
p150glued is assisted in targeting the plus-ends by another
CAP-Gly domain containing protein, cytoplasmic linker
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express a protein closely related to CLIP-170: the neu-
ronally enriched CLIP-115 [79]. Both CLIPs are ?TIPs,
but differ by the structure of their C-termini. Only CLIP-
170 contains zinc-binding domains and an EEY/F motif,
which mediate the interactions with the CAP-Gly domain
of p150glued and with the dynein regulator LIS1, as well as
autoinhibition [78, 79]. Both CLIPs also promote MT
rescue [80], although the underlying mechanism is still
obscure, as it should involve depolymerizing MT ends or
the MT lattice, where CLIPs are not enriched. Of note,
CLIP plus-end tracking behavior is less prominent in
neuronal compared to non-neuronal cells [81], which
would be compatible with a function that is not directly
related to growing MT tips. In addition to regulating
dynactin recruitment, CLIPs are enriched in axonal growth
cones, where they stabilize MTs protruding into the actin-
rich leading edge [82]. CLIPs are therefore necessary for
axon formation and outgrowth as MT stabilization in the
growth cone precedes engorgement and consolidation.
CLIP-170 is involved in dendrite morphogenesis by regu-
lating crosstalk between the actin cytoskeleton and
dynamic MTs [83]. Given the importance of CLIPs for
different processes in cultured neurons, the phenotypes of
CLIP-115 and CLIP-170 knock-out mice are rather mild,
though CLIP-115 knock-out animals do display behavioral
phenotypes [84, 85]. The loss of CLIP-190, the Drosophila
homologue of CLIP-170, causes no strong phenotype either
[81]. This suggests that the neuronal function of CLIPs
might be redundant with that of other MT regulators.
EB-dependent 1TIPs: SxIP proteins
The largest subclass of EB-dependent ?TIPs comprises
proteins which utilize a short linear motif known as the
SxIP motif (serine/threonine-any amino acid-isoleucine/
leucine–proline) to bind the EB homology domain ([42]
and reviewed in [14]). SxIP motifs are generally embedded
in unstructured amino acid stretches enriched in proline,
serine and basic residues, resulting in a positive charge
[42]. Further computational analysis revealed that the nine
amino acids surrounding the SxIP motif cannot contain
acidic amino acids, and that at least one basic amino acid is
present in the four amino acids preceding the motif [56].
Since discussing all currently identified SxIP ?TIPs is
beyond the scope of this review, we here focus on a
selection of prominent examples to illustrate the broad
range of neurodevelopmental functions of these ?TIPs. All
currently known neurodevelopmental functions are listed
per ?TIP in Table 1, along with their mode of association
with the MT plus-end and the known neurological disease
associations.
Among the most conserved SxIP proteins are CLASPs
(cytoplasmic linker protein-associated proteins), the
mammalian versions of which were discovered through
their association with CLIPs [86]. Similar to CLIPs, there
are two CLASP-encoding genes in mammals: CLASP1,
which is expressed ubiquitously, and CLASP2, the products
of which appear enriched in nervous tissue [86]. CLASPs
utilize their SxIP motifs to bind EB1 and contain several
additional TOG (tumor overexpressed gene) domains
which can serve as tubulin-binding modules [87–89]. Dif-
ferent cell lines have revealed a function for CLASPs at the
membrane, where they capture dynamic MT ends to pro-
mote MT rescue and pausing, and thus stabilize MTs [89,
90]. CLASP-mediated cortical MT stabilization is crucial
to axon outgrowth and directionality and as such, CLASP
was implicated in axon development in various organisms
[90, 91]. Interestingly, CLASPs have affinity for both the
MT plus-end and lattice, and differences in CLASP dis-
tribution and CLASP-MT associations inside the growth
cone are able to direct axon growth status. CLASPs can be
localized to the tips of growth cone filopodia, where they
capture plus-ends of MTs to facilitate axon outgrowth.
Conversely, in pausing growth cones, lattice-binding
CLASP is present close to the end of the axon shaft to
prevent MTs from protruding into the peripheral growth
cone, thereby preventing outgrowth. The localization of
CLASPs inside growth cones is regulated by kinases such
as GSK3b and Abelson kinase [90, 92–94]. In addition to
axon growth status, the direction of axon outgrowth is
regulated by CLASP localization. The kinase-controlled,
asymmetric distribution of CLASPs to the filopodia of a
growth cone determines the sites of MT capture and
thereby dictates the direction in which the axon advances
[94, 95]. Additional functions for CLASPs include a role in
synaptic functioning likely via global control of neuronal
morphology [95] and maintenance of the Xenopus growth
cone lamellipodium [91]. Furthermore, CLASP2 mediates
MT capture at the postsynaptic membrane to promote
transport of acetylcholine receptors to neuromuscular
junctions [96].
Morphological changes during neurodevelopment are
the result of complex interplay between different compo-
nents of the cytoskeleton. This is in part facilitated by the
Microtubule-Actin Crosslinking Factor proteins MACF1
(ACF7) and MACF2 (dystonin), known as spectraplakins.
As spectraplakin nomenclature is complicated, we will here
refer to MACF1/2. The reader is directed to Table 1 for a
comprehensive list of alternative names for these proteins.
Spectraplakins gain their name from membership of the
spectrin family and their plakin repeats, which grant
affinity for intermediate filaments [97]. Spectraplakins also
contain CH domains to bind to actin, GAR (growth arrest-
specific 2 protein-related region) domains to bind and
stabilize MTs [98], and SxIP motifs to bind the MT plus-
end via EBs. This places them at the heart of cytoskeletal
Microtubule plus-end tracking proteins in neuronal development 2061
123
crosstalk and renders them a popular subject for neurode-
velopmental research. Indeed, homozygous MACF1
knockout mice are not viable, and mutant mice die from
neuronal migration defects when MACF1 is depleted dur-
ing development [99]. MACF1 is known to guide MTs
along actin filaments and to mediate MT capture at actin-
rich sites near the membrane [100], consistent with a role
for MACF1 and its orthologs in growth cone MT organi-
zation and axon extension [101]. In case of the Drosophila
MACF1 ortholog Shot, this function was shown to depend
on its SxIP motifs and interaction with EB1 [63]. MACF1
has also been implicated in formation of growth cone
filopodia, although for Shot this function does not rely on
its actin- or MT-binding domains [101].
The second mammalian spectraplakin, MACF2 or dys-
tonin, is best known for its role in the neurological disorder
dystonia. MACF2 knockout mice develop dystonia and
show repetitive muscle spasms [102], and mutations in
MACF2 have been identified in patients with Hereditary
Sensory Autonomic Neuropathy [103]. These pathologies
are associated with the degeneration of sensory and auto-
nomic nerves [102, 103]. Axons of MACF2 null mice
degenerate as a result of MT fragmentation, which is
believed to contribute to the dystonia phenotype indepen-
dent of the neurofilament-binding functions of MACF2
[104]. MACF2 has also been implicated in retrograde
axonal transport by interacting with p150glued [105]. This
function may depend on MACF2’s EB-dependent associ-
ation with the MT plus-end, as overexpression of peptides
which competitively block EB–SxIP interactions inhibit
retrograde transport of endosomes [106]. Another impor-
tant factor in dystonia may be the neuron’s inability to
regulate ER stress levels, Golgi integrity, MT acetylation
and autophagy due to loss of a neuron-specific MACF2
isoform (BPAG1-a2) [107–109]. This particular isoform
has an N-terminal trans-membrane domain and does not
localize to MTs [110], although it does affect MTs near the
centrosome via an association with MAP1B [108] and
retains the C-terminal SxIP motifs. The same isoform was
shown to partially rescue phenotypes in a dystonia mus-
culorum mouse model [111]. On the other hand, another
neuron-specific MACF2 splice variant (BPAG1n3) exclu-
sively binds MTs and may be involved in sustaining axonal
MT integrity [104], suggesting distinct functions for dif-
ferent MACF2 isoforms. The same holds true for the many
splice variants of MACF1, and more research is needed to
elucidate the contribution of spectraplakin plus-end track-
ing to their functions in both nerve cells and in other cell
types.
?TIPs also play important roles in mature neurons, as
neurons remain plastic throughout their lifespan and
remodel synapses in response to both intra- and extracel-
lular cues. One such ?TIP with a function at the synapse is
p140Cap, whose name is a combination of its molecular
weight and ‘Cas-associated protein’ (Cap; Cas for Crk-
associated substrate). p140Cap is regarded as a tumor
suppressor protein due to its function as an inhibitor of Src
kinase, which is involved in cell migration and growth
[112]. In addition to its potential to associate with MT plus-
ends via an SxIP/EB3-mediated interaction, p140Cap binds
actin fibers and localizes to actin-rich dendritic spines of
hippocampal neurons [38, 112]. p140Cap knockout mice
display impaired learning and memory functions, and spine
defects have been observed in the absence of p140Cap both
in cultured primary neurons and in knockout mice [38,
113]. Synaptosomes prepared from p140Cap-/-- mice
reveal hyperactivation and hyperphosphorylation of Src
kinase and its substrate cortactin, respectively, as well as
reduced RhoA activity [113]. Research suggests that
p140Cap forms a synaptic complex with and increases the
interaction between Src kinase and Citron-N, a protein
known to scaffold the actin remodeling machinery, and as
such controls spine morphology [113]. EB3 appears to
function upstream of the spine remodeling process as
synaptic phenotypes of EB3 knockdown mimic those of
p140Cap knockdown, and can be rescued by simultaneous
overexpression of p140Cap or Citron-N [38, 113]. Notably,
while overexpressed p140Cap tracks MT plus-ends in
neurons, this is rarely the case for endogenous p140Cap.
p140Cap’s affinity for local binding partners in spines is
likely sufficiently high to prevent cytoplasmic diffusion
necessary for MT plus-end tracking behavior [38, 114]. In
addition to its function at the postsynapse, p140Cap likely
plays a role at the presynapse where it interacts with sev-
eral proteins implicated in synaptic vesicle secretion [115,
116].
Another interesting SxIP-containing partner of EB1 is
the Stromal interaction molecule 1 or STIM1 [117], a
transmembrane ER protein which contains one SxIP motif
and can thus link EB-decorated MT plus-ends to the ER
membrane. STIM1 regulates store operated calcium entry
(SOCE) in neurons and is necessary to resupply the ER
with calcium by opening plasma membrane channels after
calcium release during synaptic signaling [118, 119]. The
function of the interaction of STIM1 with MT tips is not
yet entirely clear. STIM1 participates in ER tubule exten-
sion by coupling growing MT plus-ends to the ER [117],
and it is possible that such ER remodeling contributes to
SOCE in certain cell types by bringing STIM1 in the
vicinity of the plasma membrane. Interestingly, in
HEK293T cells changes in MT dynamics affect STIM1’s
association with calcium channels [120], suggesting that in
some cell types MT dynamics are important for calcium
signaling, possibly via the action of ?TIPs. It remains to be
verified, however, what the exact contribution of STIM1’s
plus-end tracking behavior is to SOCE in neurons. Part of
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the answer may come from the function of STIM2, a
STIM1 homolog with 63 % sequence identity but without
conservation of the SxIP motif. STIM2 regulates SOCE
instead of STIM1 in pyramidal neurons of the neocortex
[121], suggesting that plus-end tracking is not required for
STIM functioning during SOCE in neurons. However,
remodeling of the ER was observed along MTs during
SOCE [122]. As STIM1 was found to remodel the ER via
its interaction with EB1 in HeLa cells [117], there is a
possibility STIM1 may exert additional, potentially plus-
end tracking-dependent functions in neurons. This is
underlined by the finding that STIM1 participates in
growth cone steering, and that this effect is only coupled to
effects on SOCE for certain guidance cues [118].
To summarize, SxIP motif-containing proteins represent
a large and heterogeneous group of EB-dependent ?TIPs,
which exert different functions at different stages of neu-
rodevelopment. Although many roles have been identified
(Table 1), it is not always clear what the contribution of
plus-end tracking behavior is to each of these functions.
Other 1TIPs
While EB proteins are responsible for targeting a large
variety of proteins to MT tips, several major classes of MT
plus-end interacting factors target the growing MT plus-
end via other mechanisms. These include the MT poly-
merase ch-TOG/XMAP215 and certain kinesin motor
proteins, such as kinesin-4, -8 and -13 family members (see
below). In addition, for some MT- or tubulin-binding
proteins, such as doublecortin and stathmin, specific
interaction with MT plus-ends was established or proposed
based on in vitro reconstitution experiments [123, 124].
However, this was not demonstrated in cells, and is
therefore not further discussed here.
ch-TOG/XMAP215 can track the growing plus-ends of
MTs directly by recognizing the outmost MT tips [125,
126], or indirectly, via EB proteins. In mammalian cells,
MT plus-end tracking of ch-TOG is facilitated by binding
to SLAIN proteins, which themselves are EB-dependent,
SxIP-containing ?TIPs that have the ability to bind a
number of other ?TIPs [127]. Both SLAIN1/2 and ch-TOG
are enriched in mammalian brain tissue, and promote MT
growth by positioning the MT polymerase at the tip of the
growing MT [128]. Like the majority of ?TIPs implicated
in maintaining MT cytoskeleton integrity, ch-TOG plays a
role in axon outgrowth. Depletion of ch-TOG increases
catastrophe rates in all subcellular compartments of rat
hippocampal neurons, while reducing MT growth rates
[128]. Axon outgrowth defects are apparent in young
neurons depleted of ch-TOG, as well as in those overex-
pressing a dominant negative SLAIN construct that
prevents ch-TOG from accumulating at the MT plus-end
[128]. In Xenopus, the ch-TOG homolog XMAP215 is
necessary for MTs to resist axon retraction induced by
contractile actin forces and thereby promotes persistent
axon outgrowth [129]. Interestingly, depletion of
XMAP215 results in an increased rate of MT plus-end
displacement specifically in the growth cone but not in
axons. This effect does not seem to depend on XMAP215’s
MT-polymerizing function, which relies on plus-end
localization, but rather seems to be a result of an additional
role for Xenopus XMAP215 in MT sliding [129].
The kinesin-4 family member KIF21A is also involved in
axon development. In HeLa cells, KIF21A is part of a cor-
tical MT-anchoring complex that includes CLASP, where
KIF21A acts as a growth inhibitor to prevent further poly-
merization of MTs that reach the cell cortex [130]. Missense
mutations in KIF21A cause Congenital Fibrosis of the
Extraocular Muscles type 1 (CFEOM1), a disease charac-
terized by the patients’ inability to control eye movements
due to defects in oculomotor nerve development [131].
These mutations were found to prevent KIF21A autoinhi-
bition, promoting increased cortical MT growth inhibition
via an EB-independent interaction of KIF21A with the MT
plus-end [130, 132]. Mutant KIF21A results in growth cone
and axon pathfinding defects in cultured neurons and
knockin mice, suggesting that improper innervation of
extraocular muscles in CFEOM1 is a result of misregulation
of MT dynamics by KIF21A [130, 132].
Regulation of interactions between microtubules
and 1TIPs
It is clear that elaborate control of the MT cytoskeleton,
which involves tight regulation of interactions between
?TIPs and MTs, is of pivotal importance to neurons.
Since many ?TIPs use the same mode of association
with EBs, competitive binding between ?TIPs from the
same subclass is a major factor in the regulation of inter-
actions. This is illustrated by the use of SxIP-motif
containing peptides to disrupt ?TIP complexes and MT
dynamics in the literature (e.g. [133, 134]), and such
competition was proposed between CLIP-115 and CLIP-
170, for example [85]. However, competition between
different subclasses has also been reported. For instance,
the SxIP-motif containing Neuron Navigator (NAV) ?TIPs
have been shown to displace p150glued from MT plus-ends
upon overexpression [135], although p150glued relies on
CAP-Gly domains to associate with EBs. Small SxIP
peptides can also abolish p150glued and CLIP binding to
MT plus-ends in in vitro reconstitution assays, confirming
that binding sites on EBs for different ?TIPs of different
subclasses overlap at least partly [133]. Additionally, it will
be interesting to see whether ?TIPs can provide indirect
Microtubule plus-end tracking proteins in neuronal development 2063
123
feedback to other ?TIPs by impacting cytoskeleton
dynamics or by affecting the conformation of EB proteins.
Not all dominant ?TIP-EB interactions negatively
impact the recruitment of other ?TIPs. For instance, EB1
is sufficient to independently recruit both p150glued and
CLIP-170 to the MT plus-end in reconstitution assays using
purified proteins, but p150glued binds the plus-end tighter
in the presence of CLIP-170 because of an additional
interaction between the two ?TIPs [133]. A similar
mechanism is employed by SLAIN2, which likely uses
interactions with multiple ?TIPs to overcome the issue of
competition [127]. Intuitively, multiplying the number of
binding modules should also increase the affinity of ?TIPs
for the MT plus-end. This has been shown for both the
repetition of SxIP motifs within individual proteins and for
increases in the number of SxIP motifs via oligomerization
[42].
Apart from effects arising from the presence of other
?TIPs at the MT plus-end, modifications of MTs or ?TIPs
provide additional layers of control. At the MT level, post-
translational tubulin modifications favor binding of certain
?TIPs over others. For example, CAP-Gly ?TIPs only
associate with MT plus-ends containing tyrosinated a-
tubulin [71, 136]. Presence of the C-terminal tyrosine on a-
tubulin also promotes MT interaction with another ?TIP,
the SxIP-containing kinesin-13 KIF2C/MCAK (mitotic
centromere-associated kinesin), which has a MT-destabi-
lizing function [137]. MAPs present on the MT lattice may
also contribute to regulation of ?TIP binding: MAP1B is
able to capture cytosolic EBs and immobilize them along
MTs, effectively lowering the concentration of EBs at the
plus-end of the MT and thereby fine-tuning axon outgrowth
[138]. Likewise, MAP2 recruits EBs to the MT lattice in
dendrites upon synaptic stimulation [139] and tau was
recently reported to bind to EB1. Tau expression levels
may also regulate EB localization, as high levels of tau
result in EB immobilization along the MT lattice [10].
At the ?TIP level, phosphorylation is considered the
classic mechanism to regulate binding. Phosphorylation of
?TIPs results in unfavorable electrostatic interactions with
negatively charged MTs and may promote ?TIP accumu-
lation at the MT plus-end rather than along the MT lattice,
or abrogate binding altogether [15, 114]. Phosphorylation
of ?TIPs in the vicinity of SxIP motifs can also suppress
binding to the negatively charged C-terminal part of EBs
and thus the plus-end tracking [42]. Many ?TIPs involved
in axon outgrowth are substrates of GSK3b [92, 140–142],
a kinase involved in prominent signaling pathways such as
the phosphoinositide 3-kinase (PI3K)/Akt pathway and
Wnt signaling. In addition to the previously discussed role
of CLASP as a GSK3b substrate during axon outgrowth,
GSK3b exerts control on the ?TIP APC during growth
cone advance [140, 143]. Binding of the spectraplakin
?TIP MACF1 to MTs is also under control of GSK3b, and
the GSK3b-MACF1 interaction plays a role in pyramidal
neuron migration [142, 144]. Interestingly, both APC and
MACF1 were suggested to regulate GSK3b activity during
Wnt signaling [145, 146], hinting at the existence of
complex feedback loops between ?TIPs and signaling
pathways during neurodevelopment.
A second kinase with strong connections to ?TIP reg-
ulation is the Abelson kinase (Abl). Together with its
substrate, Abelson interacting protein (Abi), Abl orches-
trates actin dynamics important for Drosophila axon
guidance and synaptogenesis [90] and appears to link
?TIPs to the actin remodeling machinery. The ?TIP
NAV2 can promote actin polymerization by interacting
with Abi at sites targeted by pioneer MTs [147]. Abl also
interacts with p140Cap and is required for p140Cap-me-
diated actin remodeling [148], although this interaction has
not yet been explored in neurons. Interestingly, Abl con-
trols axon guidance via CLASP, which is also under
control of GSK3b during the same process [90, 93]. Pos-
sibly, multiple signaling pathways and kinases act in
parallel on the same ?TIPs to allow additional levels of
control.
Although phosphorylation remains the best-studied
mechanism for regulation of MT-?TIP associations, other
types of regulation have started to gain attention. For
example, EB1 acetylation has been postulated to regulate
binding of the SxIP motif-containing ?TIP DDA3 during
directional cell migration [149]. Intracellular calcium
levels determine whether the MACF2 isoform BPAG1n4
localizes to the lattice or to the plus-end of MTs [150].
Finally, since individual EB proteins display different
affinities for their binding partners [56, 151], their
expression levels can also affect the composition of ?TIP
networks in manner dependent on the cell type or devel-
opmental stage.
Microtubule plus-end tracking proteins in brain
diseases
For certain neurological disorders, MT dynamics have been
examined by live imaging of ?TIPs. In the case of mul-
tiple sclerosis, a neuroinflammatory condition associated
with axonal transport defects and motor neuron degenera-
tion, the number of EB3-positive MT plus-ends was found
to increase and their directionality was altered in swollen
axons of mouse models [152]. MT plus-end dynamics were
also investigated in C. elegans after axon damage, which
can occur after spinal cord injury or stroke in humans. As
expected, axon severing generated a large amount of
dynamic MT plus-ends at the newly formed tip of the axon,
but interestingly axon regrowth depended on the C. elegans
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EB homolog EBP-1 and could be inhibited by overex-
pression the MT catastrophe-promoting protein EFA-6
(Exchange Factor for Arf6) [153]. Consistently, axon
injury or stress induced by the expression of expanded
polyglutamine proteins led to increased MT dynamics,
which had a neuroprotective role by delaying or counter-
acting neuron degeneration in Drosophila [154].
While such studies strongly imply that regulation of MT
dynamics is important in the response to neurological
damage and disease, the underlying mechanisms are still
poorly understood. Due to their diverse range of neurode-
velopmental functions, many ?TIPs are involved in human
neurological disorders (Table 1), with mutations in certain
?TIPs found to directly cause neurological disease. In this
section, we highlight two ?TIPs and associated diseases
for which the role of plus-end tracking has been investi-
gated at least to some extent: p150glued and tau-tubulin
kinase 2 (TTBK2). In addition we consider TTBK1, the
closest homolog of TTBK2.
p150glued in Perry syndrome and hereditary motor
neuropathy 7B
As described earlier in this review, p150glued is an essential
component of the retrograde axonal transport machinery by
regulating and positioning dynein at MT plus-ends. Muta-
tions in the CAP-Gly domain of p150glued, which is
required for p150glued binding to EBs and MTs [155, 156],
cause two distinct neurological disorders: Perry syndrome
and hereditary motor neuropathy 7B (HMN7B). HMN7B
affects motor neurons. Symptoms ensue in early adulthood
and include muscle atrophy, vocal fold paralysis and
breathing difficulties [157]. By contrast, Perry syndrome
(reviewed in [158]) mainly affects neurons in the substantia
nigra but not motor neurons. This rare syndrome manifests
itself around 46 years of age and is associated with parkin-
sonism, depression, hypoventilation and weight loss.
Interestingly, the p150glued mutations that give rise to
these different conditions are in close proximity: G59S
mutations cause HMN7B [157], and G71(R/E/A), T72P
and Q74P mutations were identified in Perry syndrome
patients [159]. Differences between these two diseases may
in part be explained by the effect of these mutations on the
stability of p150glued. In case of the HMN7B mutation,
mutant p150glued aggregates and is incorporated into
inclusion bodies [160, 161]. However, p150glued’s global
folding and stability is largely unaffected by Perry syn-
drome mutations [161]. This observation is reflected by the
presence of dynactin aggregates in motor neurons of
HMN7B patients [162], which are believed to contribute to
cell death [160]. Such inclusions are less common in Perry
syndrome patients [159]. All mutations disturb the
interactions between p150glued and EB proteins or MTs
[157, 159, 163], but functional differences between muta-
ted forms of p150glued were also reported. The HMN7B
mutation globally perturbs axonal transport by disturbing
dynactin binding to dynein when mutant p150glued is
incorporated in the dynactin complex. Conversely, Perry
syndrome mutations do not affect global axonal transport,
but G71R p150glued has a dominant negative effect on the
initiation of retrograde trafficking from distal axon tips
[163]. This function directly depends on p150glued’s
interaction with EB proteins at the MT plus-end [76].
Another potentially disease-related mechanism is the MT
catastrophe-suppressing function of p150glued, which is
disturbed by the Perry syndrome mutation Q74P [77].
p150glued’s ability to suppress catastrophes relies on its
binding to MTs and free tubulin dimers, and is independent
of EB proteins. p150glued isoforms harboring all domains
necessary for these interactions are primarily expressed in
neurons, rendering the effect neuron-specific.
p150glued’s involvement in Perry syndrome and HMN7B
is an excellent example of how deficiencies in plus-end
tracking can result in neurological disease. It underlines the
importance of investigating the role of plus-end tracking for
?TIPs implicated in disorders of the brain, yet surprisingly,
p150glued remains the single best-studied case.
TTBK1/2 in spinocerebellar ataxia and Alzheimer’s
disease
Two other, closely related ?TIPs firmly implicated in brain
disease are tau-tubulin kinase 1 and 2 (TTBK1 and
TTBK2). TTBK1/2 belong to the casein kinase 1 group and
share 60 % sequence identity, primarily between their
N-terminal kinase domains (reviewed in [164]). Both
TTBK proteins contain two SxIP motives in their C-ter-
minal tail [56], which is only present in vertebrates [164].
TTBK2 was the first tau-tubulin kinase to be identified,
phosphorylating MAP2 and a-casein in addition to tau and
tubulin [165]. TTBK2 is expressed ubiquitously [166] and
can phosphorylate tau at sites identified in paired helical
filament tau, a hyperphosphorylated tau variant found in
the brains of Alzheimer’s disease (AD) patients [166].
Mutations in TTBK2, which yield a mutant protein trun-
cated after the N-terminal kinase domain, cause
spinocerebellar ataxia type 11 (SCA11) [167]: a rare neu-
rodegenerative disease of which symptoms include
pronunciation difficulties, involuntary eye movement and
ataxia [168]. So far, the brain of one SCA11 patient has
been examined and revealed the presence of tau deposits
among other signs of pathological aging and cerebellar
degeneration, raising the possibility that aberrant tau
phosphorylation by mutant TTBK2 contributes to SCA11
Microtubule plus-end tracking proteins in neuronal development 2065
123
pathology [167]. In addition, TTBK2 was more recently
shown to be required for the formation of cilia by pro-
moting the removal of the centriolar capping protein
CEP110 to allow axoneme extension [169]. Diseases
resulting from cilia defects, termed ciliopathies, often
affect the brain (reviewed in [170]), and mice harboring a
mutation that prematurely truncates TTBK2 lack certain
neural cell types known to be lost in cilia-depleted animal
models [169]. Since the SCA11-mutated form of TTBK2 is
unable to initiate ciliogenesis and can interfere with the
ciliary function of full-length TTBK2, TTBK2’s function
in cilia formation provides a second explanation for the
symptoms of SCA11 [169]. However, the EB1-TTBK2
interaction plays no role in the recruitment of TTBK2 to
the basal body or in the subsequent initiation of ciliogen-
esis [171]. Recently, TTBK2 was found to phosphorylate
the kinesin-13 family member KIF2A at the plus-end of
MTs in an EB-dependent manner. This interaction regu-
lates the binding and thereby depolymerization of MTs by
KIF2A in HeLa cells [172]. The same study suggested that
TTBK2 can exist in an auto-inhibited conformation,
wherein the kinase domain is folded back onto the tail
domain containing the SxIP motifs. Binding of EB would
liberate the kinase domain and promote kinase activity,
presenting an attractive mechanism for how TTBK kinase
activity can be regulated at the plus-end of MTs [172].
Interestingly, overexpressed TTBK2 is also able to displace
EB1 from the MT plus-end, and TTBK2 affinity to MTs
itself appears to be regulated by its autophosphorylation,
suggesting that TTBK2 has the potential to regulate ?TIP-
MT associations [56]. These studies clearly signal the
importance of TTBK2’s interaction with EBs and MT plus-
ends. The direct relevance of plus-end tracking for neu-
ronal functions of TTBK2 other than ciliogenesis has not
been investigated. It is thus currently unclear whether the
functions attributed to TTBK2, such as the earlier dis-
cussed pathological tau phosphorylation, a role in neuronal
migration [172], regulation of the retrieval of synaptotag-
min-1 during synaptic vesicle endocytosis [173] or the
control of the activity of transport channels including
BGT1, a betaine/c-amino-butyric acid (GABA) transporter
[174], require TTBK2 plus-end tracking.
Full-length TTBK1 was only characterized in 2006 as a
neuron-specific kinase with the ability to phosphorylate tau
on sites associated with AD [175]. During AD, tau
becomes hyperphosphorylated, causing it to detach from
MTs and form non-soluble aggregates in the cytosol.
Certain genetic variations of TTBK1 have been linked to
lower risk of developing AD [176, 177], suggesting that
TTBK1 and variations in its expression levels may play a
role in Alzheimer pathology. Full-length TTBK1 co-lo-
calizes with EB1 and bundles MTs at high expression
levels independent of its kinase activity [56], but the
contribution of TTBK1 plus-end tracking and MT modu-
lation has never been investigated with respect to its
function or involvement in disease.
More recently, TTBK1 and TTBK2 were also shown to
phosphorylate TDP-43 (transactive response DNA binding
protein of 43 kDa) [178], the phosphorylation-driven
aggregation of which is a hallmark of amyotrophic lateral
sclerosis and frontotemporal lobar degeneration as well as
numerous other neurodegenerative diseases [179]. Under-
standing the cell biology of these kinases both in health and
disease, as well as mapping the full range of substrates of
TTBKs will be a crucial step towards the identification of
targets for therapeutic intervention.
Future outlook
As versatile regulators of the MT cytoskeleton, ?TIPs play
important roles in all aspects of neurodevelopment. It is
therefore not surprising that ?TIPs are involved in many
neurological diseases (Table 1). Although more is known
about how individual ?TIPs affect MT behavior and
integrity, in many cases this knowledge is yet to be
extrapolated to neuronal MT networks and in some cases
insight is lacking altogether.
It is crucial to develop such understanding as pharma-
cological intervention to inhibit or promote ?TIP activity,
and thereby affect specific subsets or properties of MTs,
likely provides a more elegant and refined approach to
therapy development than the use of MT targeting agents
that globally impact MT dynamics. The influence of low
doses of MT-targeting drugs on neurons has been studied
extensively and was found to impact nearly all processes in
developing and mature neurons. For example, treatment
with 15–75 nM of the MT destabilizer nocodazole impairs
the formation (but not outgrowth) of neurites in young
dissociated neurons [23]. At 200 nM, nocodazole was also
reported to inhibit primary dendrite formation [83] and has
the ability to transform mature, mushroom-headed spines
of dendrites into filopodia [38]. These morphological spine
changes are paired with decreased synaptic response [38].
The MT stabilizing drug taxol, on the other hand, is known
to induce the formation of multiple axons in young disso-
ciated neurons at concentrations as low as 3 nM [23], and
nanomolar concentrations of both MT stabilizing and
destabilizing drugs affect axon pathfinding [28]. The above
effects on neurons were mostly found to be a result of
altered MT dynamics, rather than drug-specific effects on
other cellular processes. It is therefore reasonable to
assume that treatment with other MT-targeting agents
would result in similar effects on neuronal development
and functioning.
2066 D. van de Willige et al.
123
MT-targeting agents do provide evidence that drugs
altering MT dynamics may be successful in treating brain
diseases. For example, the MT stabilizing, blood–brain
barrier-penetrant drug epothilone D shows promise as a
therapeutic agent in neurological disorders, as epothilone
D treatment partially relieves pathology in AD mouse
models [180]. Recently, the closely related MT-stabilizing
agent epothilone B also proved to stimulate regeneration
of axons after spinal cord injury in rats [181]. However,
in contrast to the global effect of MT-targeting drugs
which can yield unintended side effects, targeting indi-
vidual ?TIPs that are restricted to certain subcellular
localizations or tissues, expressed at certain times or
influence only limited aspects of MT behavior may be
preferable. Even when ?TIPs are not involved in estab-
lishing pathogenesis, they can potentially be stimulated or
inhibited to counteract MT-related disease mechanisms.
Of note, it has recently been proposed that the neuro-
protective peptide NAP possibly exerts its effects via
EBs. NAP affects the brain-specific tubulin pool as well
as MT stability and dynamics [182, 183], and has been
described to have beneficial effects in tauopathy animal
models [184–186]. NAP is believed to bind EB3 via an
alternative SxIP motif, Ser-Ile-Pro, and EB silencing in
PC12 cells obliterates the protective effect of NAP to zinc
toxicity. Although the precise mechanism remains
unclear, these data suggest that NAP’s binding to EBs
may contribute to its neuroprotective properties [187].
In summary, ?TIPs may offer a more precise approach
to interfere with pathological MT-related processes, rather
than conventional MT-targeting agents currently used in
the clinic. In order to truly establish their potential as
therapeutic targets for treatment against neurological dis-
orders, more research is needed into the functions and
mechanisms of action of an ever-growing pool of ?TIPs.
New ?TIPs are still being recognized on a large scale (e.g.
[56]), rendering the field of ?TIP research an exciting and
promising one for years to come.
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